Study Details

General Information

Altimmune Ext 106

A 12-Week Extensioin Study of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects with Non-alcoholic Fatty Liver Disease

ProtocolALT-801-106
Identifier
UID319ceb8a-f131-45af-96b8-842bd63cb8a1
StatusDone - Archived
Phase1
CategoryDiabetes Type2/Obesity / Adult
Launch Year2022
NCT Number-
Created2022-02-24 18:33
Last Updated2023-01-17 23:15

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2022-06-24No
Enrollment Open2022-03-08No
First Patient First VisitNo
Site Initiation Mtg.2022-03-07No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2023-01-17No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohseni, RizwanaRMohseniNo
Recruiter-No
CoordinatorGallardo, MichaelMGallardoNo
RegulatoryRamirez, ClaudiaCRamirezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorAltimmune, Inc.
DivisionAltimmune, Inc.
TeamAltimmune, Inc.
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROProSciento, Inc.
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?